News | News By Subject | News by Disease News By Date | Search News
Get Our FREE
Industry eNewsletter
email:    

Biotech/Pharma - Patent News
Mesoblast Limited (MSB.AX) Key Patent Allowed In Japan For The Treatment Of Heart Diseases, Stroke, And Other Vascular Conditions 3/27/2015
OXIS International, Inc. (OXIS) Biotech Executes Option Agreement To Certain Patents/Intellectual Properties Owned By The University of Pittsburgh 3/26/2015
RegeneRx Biopharmaceuticals, Inc. (RGRX) Receives Israeli Patent Acceptance Notice For The Use Of TB4 To Prevent Tissue Damage Associated With Heart Attack And Stroke Treatments 3/26/2015
Moberg Pharma AB (Formerly known as Moberg Derma) Announces Grant Of EU Patent For MOB-015 Related To Topical Treatment Of Onychomycosis (Nail Fungus) 3/26/2015
Acasti Pharma Granted Composition & Use Patent In China 3/25/2015
Moberg Pharma AB (Formerly known as Moberg Derma) Announces Issue Of U.S. Patent For Kerasal Nail 3/25/2015
Enzymotec Reports A Decision Of The U.S. Patent And Trademark Office 3/24/2015
Sunshine Biopharma, Inc. Announces Issuance Of Notice Of Allowance For The Patent Application Covering Adva-27a Anticancer Compound In India 3/24/2015
Suven Life Sciences Ltd Secures Three (3) Product Patents For Their NCEs In Canada, Japan And Korea 3/24/2015
ISA Pharmaceuticals Granted European Patent For The Intradermal Administration Of ISA101 3/24/2015
Highland Therapeutics Announces Receipt Of Two Notices Of Allowance For Patents On Lead Product 3/24/2015
BeyondSpring Extends Plinabulin IP Portfolio With Two New Method of Treatment Patent Applications 3/23/2015
Onxeo Consolidates Its Intellectual Property With The Grant Of New Patent Protection Of Validive In Japan Until 2029 3/18/2015
Key TxCell Patent To Be Granted In The United States For Its Lead Product Ovasave 3/18/2015
Daxor Corporation (DXR) Receives Notification Of Patent Approval And Issues An Update On Its Stock Buyback Program 3/17/2015
InSite Vision (ISV) Announces Settlement Of Patent Infringement Lawsuit Against Mylan Pharmaceuticals, Inc. (MYL) 3/17/2015
Suven Life Sciences Ltd Secures 2 (Two) Product Patents For Their NCE’s Through New Mechanism Of Action - H3 Inverse Agonist In USA & New Zealand 3/16/2015
Auris Medical AG (EARS) Announces Recently Granted Patent In India For The Treatment Of Tinnitus 3/13/2015
Enzymotec Granted New Patents In The United States And Australia Relevant To Phospholipid-Based Products 3/13/2015
Provectus Biopharmaceuticals Inc. Awarded PH-10 Patent By U.S. Patent And Trademark Office 3/12/2015
Federal Court Rules Millennium Health Infringes Patent Exclusively Licensed To Ameritox, Ltd. 3/12/2015
FLAG Therapeutics Announces Bi-specific FTAC Patent Issuance 3/11/2015
Highland Therapeutics Announces Notice Of Patent Allowance; Provides Update On Amphetamine Development Plans 3/10/2015
Suven Life Sciences Ltd Secures One (1) Product Patent Each In Eurasia And Israel 3/9/2015
Stevia Corp. Files Provisional Patent With The United States Patent And Trademark Office For A Non-Invasive And Simple To Use Delivery System For Cannabinoids 3/9/2015
Actavis (ACT) Confirms District Court Ruling In Atelvia Patent Litigation 3/5/2015
Islet Sciences Confirms Issuance Of U.S. Patent For Using SGLT2 Inhibitors To Treat NASH/NAFLD 3/5/2015
European Patent To Strengthen MediGene AG (MDGEF.PK)'s Dendritic Cell (DC) Vaccines Program 3/5/2015
Jaguar Animal Health Files Two Provisional Patent Applications, Deepening Its Pipeline Of Proprietary Gastrointestinal Products For Animals 3/4/2015
Cleveland Biolabs Inc. (CBLI) And Incuron Announce Growth Of Curaxin CBL0137 Patent Portfolio With U.S. Composition Of Matter Patent 3/3/2015
Regen BioPharma Files Patent Application For Treatment Of Myelodysplastic Syndrome Utilizing Gene Silencing Therapy 3/3/2015
VG Life Sciences, Inc. (VGLS) Granted Key Composition Of Matter Patent 3/2/2015
Merus Labs International Inc. Announces Settlement Of Canadian Patent Litigation 3/2/2015
CSIRO Maintains Foundational Patent For RNAi Gene Silencing Technology After European Opposition 3/2/2015
DelMar Pharmaceuticals Receives Notice Of Allowance Of Fourth U.S. Patent Covering Methods Of Use And Compositions For VAL-083 3/2/2015
University of Maryland Release: Patent Awarded For Compounds That Inhibit Formation And Persistence Of Biofilms 3/2/2015
FLAG Therapeutics Announces The Issuance Of A New U.S. Patent That Includes Composition Of Matter On Their Bi-Specific Lead Candidate For Oncology 2/27/2015
Collegium Pharmaceutical, Inc. Announces Notice Of Allowance For U.S. Patent Covering Deterx, An Abuse-Deterrent, Extended-Release, Technology Platform 2/26/2015
Meditope Biosciences Announces Issuance Of Additional Patent For SnAP Technology 2/25/2015
RegeneRx Biopharmaceuticals, Inc. (RGRX) Receives Israeli Patent For Treating And Repairing Heart Damage 2/25/2015
Ocata Therapeutics Receives Two New Patents For Immune-Modulatory Cell Technology 2/25/2015
Actavis (ACT) Confirms Generic Uceris Patent Challenge 2/25/2015
XstalBio: US Patent Issued For Stabilization Of Therapeutic Proteins 2/25/2015
iBio, Inc. (IBIO) Adds Anthrax Antibodies To Product Pipeline 2/25/2015
BioBlast Pharma (ORPN) Receives Notice Of Allowance From USPTO Covering Cabaletta For The Treatment Of OPMD 2/24/2015
BeyondSpring Files Composition Of Matter Patent Application For Plinabulin Combination Therapy In Immuno-Oncology 2/24/2015
Ciclofilin Pharmaceuticals Granted Patent In Japan For Cyclophilin Inhibitor Drugs 2/24/2015
Opsona Therapeutics Ltd. Patent Issued In USA Covering An Antibody Directed Against Toll-Like Receptor-2 (TLR-2) And The Use And Development Thereof 2/23/2015
Opsona Therapeutics Ltd. Patent Issued In US And EU Covering The Opsona-Developed Antibody OPN-305, Which Is Directed Against Toll-Like Receptor-2 (TLR-2) And The Use And Development Thereof 2/20/2015
Aegis Therapeutics, LLC Awarded U.S. Patent No. 8,927,497 For Non-Invasive Delivery Of Anti-Seizure Drugs 2/18/2015
Synageva BioPharma (GEVA) European Patent Issued For Treatment Of LAL Deficiency 2/18/2015
Can-Fite BioPharma (CFBI) Receives Notice Of Allowance In U.S. For Psoriasis Patent 2/17/2015
AdvaStim Expands Intellectual Property Portfolio With New Neurostimulation Patent 2/17/2015
Orexo AB (ORXOF) Broadens ZUBSOLV Product Range and Announces Newly Listed Granted U.S. Patent 2/17/2015
Rosetta Genomics Ltd. (ROSG) Announces Key Patent Allowances In U.S. And Europe 2/17/2015
Suven Life Sciences Ltd Secures 4 (Four) Product Patents For Their NCE’s Through New Mechanism Of Action – H3 Inverse Agonist In Australia, Canada, Japan And New Zealand 2/16/2015
AtheroNova Inc. (AHRO.OB) Receives Notice Of Issuance Of Its 3rd US Patent 2/13/2015
Kinex Pharmaceuticals Licenses Patents From Hong Kong Polytechnic University 2/13/2015
Hedge Fund Manager Picks Acorda Therapeutics (ACOR) as His First Victim Against the Pharmaceutical Industry and Its "BS" Patents 2/12/2015
RainDance Technologies Announces Patent Infringement Lawsuit Against 10X Genomics 2/12/2015
New Reverdia Patents Strengthen Biosuccinium™ Licensing 2/12/2015
iBio, Inc. (IBIO) Receives U.S. And European Patents For Protein Expression Technology 2/12/2015
AmnioLife Files Collagen Membrane Preservation Patent 2/11/2015
Novogen Limited (NVGN) Lodges Key Super-benzopyran Patent 2/11/2015
Moberg Pharma AB (Formerly known as Moberg Derma) Announces Issue Of U.S. Patent Related To MOB-015 For The Treatment Of Onychomycosis 2/11/2015
Cleveland Biolabs Inc. (CBLI) Announces Expansion of Entolimod Patent Portfolio With New Composition of Matter Patents 2/11/2015
Cara Therapeutics, Inc. (CARA) Issued Additional U.S. Patent Covering The Expanded Use Of Kappa Opioid Receptor Agonist CR845 And Analogs For The Treatment And Prevention Of Pain-Related Conditions 2/10/2015
Drawbridge Pharmaceuticals Granted Notice Of Allowance For Divisional Patent In The United States 2/10/2015
Pivotal Therapeutics Inc. Announces The Issuance Of Two Patents Both Related To The Combination Of VASCAZEN® With Key Cholesterol Lowering Agents (Statins) And Cholesterol Absorption Inhibitors 2/10/2015
BrainStorm Cell Therapeutics Inc. Receives Notice Of Allowance For Its Nurown Technology Platform From Israel's Patent Office 2/9/2015
MicroBiome Therapeutics LLC Receives Notice Of Allowance For U.S. Patent Covering Glyceollin As A Treatment For Diabetes And Obesity 2/9/2015
Mylan Inc. (MYL) Confirms First-to-File Patent Challenge Relating To NEXAVAR 2/9/2015
VBL Therapeutics (VBLX) Receives European Patent Issuance On Lecinoxoid Platform Technology 2/6/2015
Creative Medical Health Files Patent On Multiple Sclerosis Stem Cell Therapy 2/6/2015
NeuroNascent, Inc. Announces Expanded Patent Coverage In US And Russia For Its Alzheimer's Disease And Down Syndrome Therapeutics 2/5/2015
Horizon Pharma plc.  (HZNP) Announces Issuance Of VIMOVO® Related Patent With Protection To 2031 From United States Patent And Trademark Office 2/5/2015
ContraVir Pharmaceuticals' HBV Compound CMX157 Receives Extended Patent Life 2/4/2015
iBio, Inc. (IBIO) Adds To iBioModulator Portfolio And Product Pipeline 2/4/2015
MediciNova, Inc. Receives Notice Of Allowance For New Patent Covering MN-001 And MN-002 For The Treatment Of NASH 2/4/2015
Aurinia (ISA.TO) Announces Recently Granted Nanomicellar Formulation Patents In Japan And China For Topical Ophthalmic Administration Of Voclosporin 2/4/2015
Oxis Biotech Inc. Provides Update For P62-ZZ Multiple Myeloma Patent Application 2/4/2015
ProLynx Issued Key Patent For Using Releasable Linkers On Insoluble Carriers 2/4/2015
ARCA biopharma Announces Patent Issuance For Methods And Compositions Of S-Isomer Formulation Of Gencaro 2/4/2015
Enzymotec Announces Favorable Response From The Australian Patent Office 2/3/2015
RXi Pharmaceuticals (RXII) Strengthens Intellectual Property Portfolio For Ocular Indications 2/3/2015
EastGate Biotech Provides Update On Its Patent Portfolio 2/3/2015
MMRGlobal Biotech Assets In Play As Company Is Awarded Second U.S. Cancer Fighting Patent 2/2/2015
MediciNova, Inc. Receives New Patent Covering MN-029 (denibulin) di-hydrochloride In Japan 1/30/2015
VG Life Sciences, Inc. (VGLS) Announces Issuance Of Patent Covering Treatment Of Inflammatory Bowel Disease With Clip-Inducing Agent 1/29/2015
Apricus Biosciences (APRI) Announces Issuance Of U.S. Patent For Rayva™ 1/28/2015
Adamis Pharmaceuticals (ADMP) Receives Notice Of Allowance For U.S. And Japanese Patents For Its Dry Powder Inhaler 1/28/2015
Garnet Biotherapeutics, Inc. Files Amicus Brief To Support Its Victory Against Athersys, Inc. (ATHX) In Patent Interference 1/28/2015
BioTime (BTX) Announces Issuance Of 14 New Patents In The Fields Of Regenerative Medicine, Stem Cell Technology, And Cancer Therapy 1/26/2015
Provectus Biopharmaceuticals Inc.’ Novel Synthesis Patent Application Allowed By Chinese Patent Office 1/26/2015
KannaLife Sciences, Inc. Files PCT Patent Application For Novel Treatments for Neurodegenerative Disorders 1/23/2015
European Patent Office Issues Key Patent To TiGenix For Expanded Adipose-Derived Stem Cell Compositions 1/22/2015
Supernus Pharmaceuticals (SUPN) Sues TWi Pharmaceuticals, Inc. For Infringement Of Oxtellar XR® Patents 1/22/2015
Ablynx (ABLYF) Successfully Opposes Patent Appeal Case By Domantis Limited (GlaxoSmithKline (GSK)) 1/22/2015
Fuisz Pharma Announces New Patent Allowance For Its Helicopter™ Tablet Shape With Improved Swallowability; Adds To Existing Tablet Shape Patent Estate 1/20/2015
Mylan Inc. (MYL) Release: U.S. Supreme Court Partially Modifies Standard Of Review Of Patent Claim Construction And Remands Review Of Teva's '808 Patent On Copaxone® To Federal Circuit Court Of Appeals 1/20/2015
Suven Life Sciences Ltd Secures One (1) Product Patent Each In Australia & Hong Kong, Two (2) Product Patents From Japan 1/20/2015
Supernus Pharmaceuticals (SUPN) Sues Par Pharmaceutical Companies, Inc. (PRX) For Infringement Of Trokendi XR® Patents 1/19/2015
Akorn, Inc. (AKN) Confirms Generic Durezol® Patent Challenge 1/16/2015
Vanda Pharmaceuticals, Inc. (VNDA) Announces Listing of a New Fanapt® Patent In The FDA Orange Book 1/16/2015
Oramed Pharmaceuticals Inc. (ORMP) Granted Patent In Israel For Oral Administration Of GLP-1 1/16/2015
Spotlight Innovation Subsidiary Celtic Biotech Iowa Granted Patent By The U.S. Patent And Trademark Office 1/16/2015
3SBio Inc. (SSRX) Signs Exclusive Patent License Agreement For DIG-KT, A Bi-Specific mAb Targeting VEGFR2 And Tie-2 With Pharmabcine 1/15/2015
Gilead (GILD)'s India Patent Roadblock May Spur More Sovaldi Copies 1/15/2015
DelMar Pharmaceuticals Receives Notice Of Allowance For Third US Patent For VAL-083 1/13/2015
NanoSphere Health Sciences Announces Patent-Pending Status For Nanoparticle Encapsulation Of NSAIDs 1/13/2015
OncoSec Medical Inc. Obtains Allowance Of Key Patent Application For Intratumoral Delivery Of Plasmid IL-15 1/13/2015
BioD Receives U.S. Patent For Unique Placental Tissue Technology 1/12/2015
Aradigm Corporation (ARDM) Granted Key Composition Of Matter Patents For Pulmaquin In Europe And Australia 1/12/2015
Silver Bullet Therapeutics Announces Issuance Of U.S. Patent No. 8,927,004 For Bioabsorbable Substrates That Controllably Release Metal Ions 1/12/2015
Chimerix, Inc. (CMRX) Receives Notice Of Allowance For Brincidofovir Composition Of Matter Patent Extending Exclusivity To 2034 1/12/2015
Altos Therapeutics Receives Second Issued Patent Covering Novel Dopamine D2/D3 Antagonists For The Treatment Of Gastrointestinal Diseases 1/12/2015
Oxis Biotech Executes Worldwide Exclusive Patent Licensing "P62 Chemical Agents And Multiple Myeloma Therapeutics" With Dr. Xiang-Qun (Sean) Xie, Professor Of Pharmaceutical Sciences At University of Pittsburgh 1/12/2015
Helsinn Healthcare SA Reaches Settlement Agreement Regarding Patent Dispute On ALOXI® 1/12/2015
Dicerna Pharmaceuticals (DRNA) Announces Issuance Of US Patent Providing Broad Coverage Of DsiRNA-EX RNAi Payloads 1/12/2015
SciFluor Life Sciences, LLC Awarded U.S. Patent For KCNQ2/3 Activator Designed For Treatment Of Epilepsy And Related Neurological Disorders 1/8/2015
Pluristem Therapeutics (PSTI) Granted Patent For Foundational Cell Harvesting Technology In South Africa 1/6/2015
Biomatrica Announces Patent Award For Novel Method Of Stabilizing And Storing Biological Materials To Improve Downstream Testing 1/6/2015
Cellectis (ALCLS) Announces The Issuance By The USPTO Of A Patent Covering A Seminal Nuclease-Based “Gene Editing” Method 1/6/2015
RestorGenex Announces Issuance Of European Patent For Its Dermatology Program 1/5/2015
Alzheon Announces Patent Allowance In Europe For ALZ-801 In Development For Alzheimer’s Disease 1/5/2015
Suven Life Sciences Ltd Secures Three (3) Product Patents In Eurasia, Japan, And Mexico 12/30/2014
Repros Therapeutics Inc. (RPRX) Confirmed As Sole Owner 12/29/2014
Nuvo Research Inc. (NRI.TO) Granted Additional U.S. Patent For Treatment Of Allergic Rhinitis With WF10 12/22/2014
TWi Biotech Receives Notice Of Patent Allowance For Its Lead Drug Candidate AC-201 For The Indication Of Type II Diabetes In China 12/22/2014
Prima Biomed (PRR.AX) Announces Immutep S.A.'s IMP321 Patent Application Receives Canadian Patent Office Notice Of Grant 12/22/2014
Harbour Antibodies Announces First U.S. Patent For Novel Transgenic Mouse Antibody Technology For Next Generation Therapeutic Antibody Discovery 12/19/2014
Anergis Granted U.S. Patent For Ragweed Allergy Vaccine AllerR 12/19/2014
Regeneus (RGS.AX) (ASX:RGS) Patent Granted For Protecting Cryopreserved Stem Cells 12/19/2014
Sienna Labs Obtains Sixth Patent Relating To Use Of Plasmonic Nanoparticles In Treatment Of Sebaceous Glands And Hair 12/19/2014
Celator Pharmaceuticals, Inc. Receives European Patent Allowance On Nanoparticle Delivery Technology 12/18/2014
Pronutria Biosciences Announces Issuance Of Key Patents From USPTO On Compositions And Methods Relating To Oral Biologics 12/18/2014
BioBlast Pharma (ORPN) Receives Notice Of Patent Issuance From USPTO For Its Novel Fusion Protein-Based Platform For The Treatment Of Friedrich's Ataxia 12/17/2014
ImmunoCellular Therapeutics, Ltd (IMUC) Announces Issuance Of Key Patent For ICT-107 Cancer Vaccine 12/17/2014
Elite Pharmaceuticals, Inc. (ELI) Awarded Second Canadian Patent For Abuse Deterrent Drug Formulation 12/16/2014
United States Patent Office Grants Apnea Sciences Patent 12/16/2014
SomaGenics Inc. Awarded Four Patents Spanning Its miRNA And RNAi Programs 12/16/2014
TherapeuticsMD, Inc.  (TXMD) Receives Five New Patent Allowances, Further Strengthens IP Assets 12/16/2014
Biocept, Inc. (BIOC) Expands Worldwide Microchannel Patent Protection To South Korea 12/15/2014
Heptares Extends Global Patent Protection For GPCR-Focused Drug Discovery Platform With Grant Of Core Patents In The United States 12/15/2014
Wilshire Confirms First-to-File Patent Challenge Relating To LASTACAFT 12/12/2014
Suven Life Sciences Ltd Secures (5) Product Patents For Their Nces In Israel, Japan, China And New Zealand 12/12/2014
MediciNova, Inc. Receives Notice Of Allowance For New Patent Covering MN-001 And MN-002 For The Treatment Of Liver Disorders 12/10/2014
MultiCell Technologies Inc. (MCET.OB) Files Novel Antibody-Drug Conjugate Patent Application 12/10/2014
Nordic Nanovector Patent Granted In Japan 12/10/2014
NeuroMetrix, Inc. (NURO) Expands Intellectual Property For Wearable Pain Relief Technology 12/10/2014
Novadaq Technologies, Inc. Granted Additional SPY Technology Patent Protection In The U.S. 12/9/2014
Cubist Pharmaceuticals, Inc. (CBST) Comments On CUBICIN Patent Litigation 12/9/2014
KemPharm, Inc. Receives Notice Of Allowance For NME Prodrug Of Methylphenidate, KP415 12/5/2014
SciFluor Life Sciences, LLC Awarded U.S. Patent For Integrin avß3 Inhibitors Designed For The Topical Treatment Of Retinal Disease 12/4/2014
Adamas Pharmaceuticals (ADMS) Issued Six Additional U.S. Patents 12/4/2014
Keryx Biopharmaceuticals (KERX) Announces Issuance Of A New U.S. Patent For Auryxia (Ferric Citrate) Covering Orally Administrable Forms 12/4/2014
THERAVECTYS Further Strengthens The Intellectual Property Of Its Lentiviral Vector Technology 12/3/2014
Sienna Labs Obtains Fifth Patent Relating To Use Of Plasmonic Nanoparticles In Treatment Of Sebaceous Glands And Hair 12/3/2014
Milo Biotechnology Announces Patent Issuance 12/3/2014
GlySure Strengthens Intellectual Property Portfolio With Three New Patents 12/3/2014
Galena Biopharma  (GALE) Receives Notice Of Allowance Of U.S. Patent Application For GALE-401 (Anagrelide Controlled Release) Composition Of Matter 12/2/2014
IntelGenx Corp. Announces Update To Settlement Of U.S. Patent Litigation Related To Forfivo XL 11/26/2014
Mylan Inc. (MYL) Confirms First-To-File Patent Challenge Relating To BREVIBLOC 11/25/2014
Xenetic Biosciences Provides Update On Substantial Patent Grants And Allowances In U.S. and Worldwide 11/25/2014
Supernus Pharmaceuticals (SUPN) Files Lawsuit Against Zydus Pharmaceuticals (USA) Inc. In U.S. Court For Infringement Of Patents Covering Its Antiepileptic Drug, Trokendi XR 11/25/2014
Regen BioPharma Acquires University of Toronto Cancer Stem Cell Intellectual Property 11/25/2014
Arena Pharmaceuticals, Inc. (ARNA) Issued Composition Of Matter Patent By United States Patent And Trademark Office For Ralinepag And Related Compounds 11/25/2014
IntelGenx Corp. Announces Settlement Of U.S. Patent Litigation Related To Forfivo XL 11/25/2014
ChromaDex, Inc. Announces Two Patent Issuances For Novel Ingredient, Pterostilbene 11/24/2014
Forward Pharma (FWP) Receives Issue Notification For Erosion Matrix Patent In The U.S. 11/24/2014
Supernus Pharmaceuticals (SUPN) Announces Issuance Of Fifth U.S. Patent Protecting Trokendi XR(R) 11/24/2014
Catalyst Pharmaceuticals (CPRX) Announces Notice Of Allowance Of U.S. Patent Application For The Reduction Or Elimination Of Visual Field Defects By Treating Patients With CPP-115 11/24/2014
Ebola Vaccine Running Into Patent Cover In Canada? 11/21/2014
Orexigen Therapeutics, Inc. (OREX) Announces Allowance Of New U.S. Patent For Contrave (Naltrexone Hcl / Bupropion Hcl Extended Release) 11/21/2014
Highland Therapeutics Receives Second Notice Of Allowance For Patent On Lead Product 11/20/2014
Seegene, Inc. Receives US Patent For TOCE Technology 11/19/2014
Aphios Granted United States Patent For Nanotechnology Co-Encapsulation Of Combination Drugs & Drug Products 11/18/2014
3SBio Inc. (SSRX) Signs Exclusive Patent License Agreement For Tanibirumab, An Anti-VEGFR2/KDR Mab With Pharmabcine 11/18/2014
OXiGENE (OXGN) Announces Issuance Of European Patent for OXi4503 In Acute Myeloid Leukemia And Other Myeloid Malignancies 11/17/2014
Regeneus (RGS.AX) Acne Treatment Patent Granted 11/14/2014
AbbVie (ABBV) Uses Patents To Ambush Gilead (GILD) 11/14/2014
Foamix Pharmaceuticals, Ltd. (FOMX) Announces Two New U.S. Patents Relating To Topical Tetracycline Compositions 11/13/2014
Highland Therapeutics Receives Notice Of Allowance For Patent On Lead Product 11/13/2014
BioLargo, Inc. (BLGO.PK) Issued Patent For Its Platform Of Liquid And Hydrogel Iodine Technologies 11/13/2014
Pluristem Therapeutics (PSTI) Granted Patents In Australia And New Zealand For Use Of Placental Cells In The Treatment Of Multiple Indications 11/12/2014
New U.S. Patent Issued To Dyadic International, Inc. 11/12/2014
Aegis Therapeutics, LLC Awarded Patent For Intranasal Administration Of Active Agents To The Central Nervous System 11/12/2014
Horizon Pharma plc.  (HZNP) Announces Favorable Markman Ruling in RAYOS® (prednisone) Delayed-Release Tablets Patent Infringement Litigation 11/12/2014
Genovis Sues U.S. Company For Patent Infringement 11/11/2014
Matinas BioPharma Receives Notice Of Allowance Of U.S. Patent For MAT9001 11/10/2014
Supernus Pharmaceuticals (SUPN) Announces Issuance Of Fourth U.S. Patent Protecting Trokendi XR® 11/7/2014
ViaCyte, Inc. (Formerly Known as Novocell, Inc.) Receives U.S. Patent Claiming Alternative Methods to Manufacture Pancreatic Progenitor Cells In Vitro 11/6/2014
PuriCore Granted Two U.S. Patents 11/5/2014
Reflect Scientific, Inc. Files Patent For Low Temperature Freezer Technology 11/4/2014
OncoMed Pharmaceuticals, Inc. (OMED) Granted Anti-DLL4/Anti-VEGF Bispecific Antibody Patent In The U.S. 11/3/2014
U.S. Patent Office Significantly Extends The Term Of Three RegenRx Patents 11/3/2014
AmnioLife Files U.S. Patent Application 10/31/2014
Cipla Ltd. Asks Government To Revoke Five Patents Held By Novartis AG (NVS) 10/30/2014
Levolta Pharmaceuticals Receives U.S. Patent For Novel Investigational Therapy For Controlling Osteoarthritis 10/30/2014
When Will Biosimilars Impact The U.S. Market? 10/30/2014



//-->